The challenges of drug resistance with targetted cancer therapies @yourgenome
The challenges of drug resistance with targetted cancer therapies @yourgenome
Uploaded June 2013 | Updated September 2026, 1 hour ago
Wellcome Trust Sanger Institute researcher Ultan McDermott discusses the challenges of drug resistance with targeted cancer therapies.

This video has been produced to accompany a classroom activity: BRAF: from gene to cancer therapy that has been developed by the Public Engagement team at the Wellcome Trust Sanger Institute.

Find out more about cancer on our website: yourgenome.org/theme/is-cancer-a-genetic-disease
The challenges of drug resistance with targetted cancer therapiesMy career in genomics: conservation geneticsDNA Sequencing - 3DAbout the diseaseCan we sequence the DNA of dinosaurs?What are somatic mutations?My career in genomics: genetic counsellingPCR explained | biology animationJohn Sulston: How did I become involved in the Human Genome Project?My career in genomics: evolutionHow big is the human genome?Why is ancient DNA difficult to work with?
yourgenome |

The challenges of drug resistance with targetted cancer therapies

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER